How to check GLP-1 coverage with Kaiser Permanente
Verified coverage details by drug are below, followed by the process for checking your own plan.
Sources last checked September 21, 2026
Kaiser Permanente is a group of regional health plans and medical groups, not one national insurance contract. Formularies, pharmacies, and phone numbers differ by region. The numbers below are only those published on a region’s dedicated member-services page; for every other region, use the number on your ID card.
What we've verified about Kaiser Permanente GLP-1 coverage
Ozempic
Kaiser Northwest lists injectable semaglutide (Ozempic) with criteria-based coverage with nine initiation pathways. Type 2 diabetes pathways generally require HbA1c above 6.9% and below 10% after dual-therapy trials (metformin and others), or ASCVD or proteinuria variants, with no MTC or MEN 2 history. Weight, OSA and MASH pathways require failed trials of two weight-loss drugs and are only covered for members whose plan includes weight-loss drug coverage.
Source: Kaiser Permanente Northwest: Criteria for Drug Coverage, Injectable semaglutide (Ozempic), Revised 2026-04-09; effective 2026-06-04
Mounjaro
Kaiser Northwest treats tirzepatide (Mounjaro) as non-formulary and covers it only through a criteria-based consultation program. For type 2 diabetes in adults it requires maximally tolerated metformin and other agents plus prior liraglutide and semaglutide failure, with HbA1c between 6.9% and 10%. Renewal for the weight-management pathway requires sustained 5% weight loss, and weight-loss use only applies to members with weight-loss drug coverage.
Source: Kaiser Permanente Northwest: Criteria for Drug Coverage, tirzepatide (Mounjaro), Revised 2026-02-12; effective 2026-03-05
Wegovy
Kaiser Northwest treats Wegovy as non-formulary, covered on the pharmacy benefit for 12-month approval periods when criteria are met. It covers chronic weight management, pediatric obesity (12 to 17), cardiovascular risk reduction and MASH, and generally requires a 3-month trial and failure of at least two alternative weight-loss medications plus prior Ozempic failure for most indications. Members without weight-loss drug coverage pay the member cash price.
Source: Kaiser Permanente Northwest: Criteria for Drug Coverage, semaglutide (Wegovy), Revised 2025-12-11; effective 2026-02-05
Zepbound
Kaiser Northwest treats Zepbound as non-formulary and requires a clinical review. Initiation needs a 3-month adequate trial of at least two alternatives (phentermine, diethylpropion, topiramate, Qsymia, Contrave) and a 6-month semaglutide trial before tirzepatide, with indications of chronic weight management (BMI 30+, or 27+ with comorbidity) or OSA without diabetes. Continuation needs 5% or greater weight loss at annual review.
Source: Kaiser Permanente Northwest: Criteria for Drug Coverage, tirzepatide (Zepbound), Revised 2025-06-12; effective 2025-08-07
Formularies differ by employer, state, Medicare vs. commercial, and PBM carve-out. The only reliable answer is the number on your ID card plus a written prior-auth decision.
Full 5-step checklist →Who to call
If a regional number below disagrees with your card, use the card. We only list California and Mid-Atlantic here because those are the regions whose dedicated member-services pages we verified.
Member Services, Monday through Friday, 7:30 a.m. to 5:30 p.m.
Official contact directory: Kaiser Permanente member site (kp.org).
How prior authorization usually works here
- Because Kaiser is integrated, coverage questions often go through your Kaiser pharmacy or your Kaiser clinician rather than an outside PBM. Start with the Member Services number for your region, or the pharmacy number on your prescription label.
- Look up your region’s drug formulary on kp.org (each region publishes its own). A Southern California formulary does not speak for Mid-Atlantic or any other Kaiser region.
- If a GLP-1 requires review, ask your Kaiser prescriber or the pharmacy to initiate it. In some Kaiser regions, “prior authorization” is an internal clinician review rather than a member-submitted insurance form.
- Ask whether your plan is a Kaiser HMO, a Kaiser added-choice/PPO-style product, Medicare Senior Advantage, or Medicaid/Medi-Cal — the pharmacy rules are not the same.
- If the drug is non-formulary in your region, ask Member Services how to request a non-formulary exception or (for Medicare) a coverage determination. Do not assume another Kaiser region’s policy applies.
What to ask on the call
- Which Kaiser region and which plan type am I on (HMO, added-choice, Medicare, Medicaid)?
- Is [drug name] on my region’s formulary for [diagnosis]?
- If it needs review, does my Kaiser clinician submit that internally, or is there a separate pharmacy coverage-determination form?
- What is the cost at a Kaiser pharmacy vs. mail-order, and are there quantity limits?
- If it is non-formulary, what is the exception or grievance process for my region?
By drug
- Does Kaiser Permanente cover Ozempic?
- Does Kaiser Permanente cover Mounjaro?
- Does Kaiser Permanente cover Wegovy?
- Does Kaiser Permanente cover Zepbound?
All insurers with published drug pages
Other major insurers
Manufacturer savings programs and cash-pay telehealth are the usual next step — they still depend on your situation, not on this page.
See Cash-Pay Options →Phone numbers and portal names are taken from Kaiser Permanente's public contact pages linked above. They change, and they are not a substitute for the number printed on your ID card. This page does not make coverage claims for any GLP-1 medication.